Baculovirus system for the expression of a gene therapy vector
US10017783B2 · kind B2 · utility
1Cited by
0References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 27, 2012 |
| Grant date | Jul 10, 2018 |
| Priority date | — |
| Expiry date | Jul 27, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2999/007
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention relates to a recombinant baculoviral genome useful for the production of viral vectors for gene therapy, allowing said production from a single infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.